AzTrials
AzTrials

Neck PainNCT02261259

Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System

A study testing Osteopathic manipulative treatment in people with Neck Pain, run by Michigan State University at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of head-neck motor control. In order to accomplish this goal, the investigators aim to quantify changes in head-neck motor control before and after osteopathic manipulative treatment. Read more about this study

Who is it for?
Ages 21 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Neck Pain
What is being tested?
Osteopathic manipulative treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
154 participants
Where
3 sitesUnited States
Study dates
26 Jun 2014to 13 Nov 2017
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All participants must meet all of the inclusion criteria to participate in the study. Below is a list of inclusion criteria for ALL participants:
  • Age 21-65 years
  • Independently ambulatory
  • Able to speak and read English
  • Able to understand study procedures and to comply with them for the entire length of the study.
  • Below is an additional list of inclusion criteria for NECK PAIN participants:
Show all 10Show fewer
  • Willing to be randomized to either immediate or delayed treatment group.
  • Musculoskeletal pain - primarily in the cervical region lasting longer than 3 months
  • Pain rating greater than or equal to 3 out of 10 as indicated on the Numeric Rating Scale for Pain
  • Neck Disability greater than or equal to 30% as indicated on the Neck Disability Index

Who cannot join

  • All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation. Exclusion criteria will be self-reported. However, during each treatment session, the physicians will be watching for clinical signs and symptoms not consistent with physical findings that are suggestive of the presence of any of the exclusion criteria. In such a case, further treatment will be discontinued and the subject will be excluded.
  • Below is a list of exclusion criteria for ALL participants:
  • Inability or unwillingness of individual to give written informed consent.
  • Physical therapy or any other form of manual medicine (e.g., Osteopathic Manipulative Medicine, Chiropractic Manipulation, etc.), acupuncture or spinal injections within one month prior to study enrollment
  • Workers' compensation benefits in the past 3 months or ongoing medical legal issues
  • Possibly pregnant
Show all 36Show fewer
  • Extreme obesity (BMI>36)
  • Currently using electrical implants (e.g., cardiac pacemakers, drug delivery pumps, etc.)
  • History of:
  • Spinal surgery
  • Spinal fracture
  • Spinal infection (e.g., osteomyelitis)
  • Cancer
  • Unresolved symptoms from:
  • Head trauma
  • Inner ear infection with associated balance and coordination problems
  • Orthostatic hypotension
  • Uncontrolled hypertension
  • Vestibular disorder (e.g. vertigo)
  • Current diagnosis of:
  • Significant spinal deformity (e.g., scoliosis > 20 degrees, torticollis)
  • Ankylosing spondylitis
  • Spondylolisthesis grades III or IV
  • Rheumatoid arthritis
  • Osteoporosis
  • Angina or congestive heart failure symptoms
  • Active bleeding or infection in the back
  • Blindness
  • Seizures
  • Neurologic disease (e.g., Parkinson's disease, multiple sclerosis, cerebral palsy, Alzheimer's disease, amyotrophic lateral sclerosis, stroke or transient ischemic attack in the past year, cervical dystonia)
  • Conditions recognized by a physician any time during the study:
  • Significant or worsening signs of neurologic deficit
  • Symptoms are not consistent with mechanical findings
  • Other conditions impeding protocol implementation
  • Below is an additional exclusion criterion for healthy control participants:
  • Based on the minimal clinically important difference of 2 points (Childs et al., 2005), "healthy controls" with 2 points or greater pain on NRS will not be eligible to participate.

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • MSU Osteopathic Manual Medicine

    East Lansing, Michigan, 48823

  • MSU Musculoskeletal Rehabilitation

    Lansing, Michigan, 48891

  • Michigan State University Center for Orthopedic Research

    Lansing, Michigan, 48910

Other trials in United States

About this study

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of head-neck motor control. In order to accomplish this goal, the investigators aim to quantify changes in head-neck motor control before and after osteopathic manipulative treatment. The investigators hypothesize that head-neck motor control will improve in neck pain participants after 4-weeks of treatment. Additionally, the investigators will compare position and force head-neck motor control between healthy controls and neck pain patients. The investigators hypothesize that baseline tests of position and force head-neck motor control will be better in healthy individuals than neck pain patients.

Conditions
Neck Pain
Being tested
Osteopathic manipulative treatment, No intervention
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Osteopathic manipulative treatmentProcedure or surgery

    Up to 4 sessions of osteopathic manipulative treatment (once per week)

  • No interventionOther

    No interventions for approximately 4 weeks

Study groups in NCT02261259
Study groupRoleWhat they receive
OMT first, then No interventionExperimentalThis arm received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week), then received no intervention after for approximately 4 weeks.
Receives: Procedure: Osteopathic manipulative treatment; Other: No intervention
No intervention, then OMTExperimentalThis arm received no intervention after for approximately 4 weeks, then received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week).
Receives: Procedure: Osteopathic manipulative treatment; Other: No intervention
Healthy control (no neck pain)No interventionIn this arm, healthy controls are tested at baseline.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Head Position Tracking Accuracy (Flexion/Extension)

    Participants will be seated in an upright position with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The angular position of the head will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by moving their head. Accuracy will be determined by taking the difference between the target position signal and the actual head position (root mean square error measured in degrees with string potentiometers).

    Measured: Measurements from Baseline, Week 4 and Week 8

  2. Head Force Tracking Accuracy

    Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. The pad will be attached to a load cell that monitors how much force is being generated by their head. The force level will be displayed on a monitor 1 meter in front of the participants and they will be asked to follow a moving target by generating force with their head. Accuracy will be determined by taking the difference between target force signal and the actual head force (measured in Newtons with the load cell).

    Measured: Baseline, Week 4, and Week 8

  3. Head Position Stabilization Accuracy

    Participants will be sitting upright in a seat mounted to a robotic platform (Mikrolar Hexapod Robot) with their upper body secured to a backrest and will wear a head harness with an attached position sensor. The robotic platform will provide an angular perturbation to the participant about the cervical spine in the sagittal plane while the participant is asked to maintain (stabilize) their head position in the upright posture with their eyes open. Accuracy will be determined by measuring the amount of head displacement (measured in degrees with string potentiometers) during the perturbation trial.

    Measured: Baseline, Week 4, and Week 8

  4. Neck Force Variability

    Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. They will be asked to performed 6-seconds isometric exertions in different directions. Measured forces are converted to moments (in Newton meters), and standard deviation of the moments are reported for flexion and extension. Larger the number in the variability indicates worse performance.

    Measured: Baseline, Week 4 (crossover), Week 8

  5. Neck Muscle Activation Directionality

    Participants will be seated in an upright position with their upper body secured to a backrest and will be asked to generate force with their head against a fixed pad. They will be asked to performed 6-seconds isometric exertions in different directions. Surface EMG will be recorded from the sternocliedomastoid (SCM), splenius capitis (SPC), and upper trapezius (UT) muscles. Muscle directionality will be determined from the EMG magnitude in each direction of exertion and represented as specificity index. Specificity index ranges from 0 to 1, where 0 indicates no muscle activity and 1 indicates the highest muscle activity. Higher number indicates worst outcome.

    Measured: Baseline, Week 4 (crossover), Week 8

Secondary outcomes (4)
  1. Patient Reported Outcomes Measurement Information System (PROMIS)

    Assesses weekly changes in physical function, anxiety, depression, fatigue, sleep, satisfaction with social role, and pain with PROMIS-29 questionnaire.

    Measured: Measurements from Baseline and Week 4 (crossover point)

  2. Change in Concomitant Medication

    Assesses weekly changes in the use of medication with a questionnaire. Patients were asked to report medications used within the past 7 days.

    Measured: Baseline, Week 4, Week 8

  3. Change in Neck Disability

    Assesses weekly changes in functional activities related to neck disability with the Neck Disability Index questionnaire.

    Measured: Measurements from Baseline, Week 4 (crossover point), and Week 8

  4. Change in Fear Avoidance Behavior

    Assesses weekly changes in fear avoidance behavior using the Fear Avoidance Beliefs questionnaire, assessing effects of fear-avoidance beliefs about physical activity and work. Patients rated statements on a scale from 0 (completely disagree) to 6 (completely agree). Scores are then summed for each category: "Physical activity" (total of 4 statements, ranges from 0 to 24), and "Work" (total of 7 statements ranges from 0 to 42). Higher scores indicate stronger fear-avoidance belief (i.e. worse outcome).

    Measured: Measurements from Baseline, Week 4 (crossover point), and Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2014 (estimated)
  2. Study start26 Jun 2014
  3. Primary completion13 Nov 2017
  4. Study completion13 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
154 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02261259
Sponsor's protocol ID
NCCAM U19 AT006057 Project 3
Other IDs
5U19AT006057-02
Status last verified
Mar 2026
First submitted
19 Sep 2014
Last updated
20 Oct 2026
Data monitoring committee
Yes

Publications

  • Reeves NP, Popovich JM Jr, Priess MC, Cholewicki J, Choi J, Radcliffe CJ. Reliability of assessing trunk motor control using position and force tracking and stabilization tasks. J Biomech. 2014 Jan 3;47(1):44-9. doi: 10.1016/j.jbiomech.2013.10.018. Epub 2013 Oct 22.

    PubMed 24262851
  • Popovich JM Jr, Reeves NP, Priess MC, Cholewicki J, Choi J, Radcliffe CJ. Quantitative measures of sagittal plane head-neck control: a test-retest reliability study. J Biomech. 2015 Feb 5;48(3):549-54. doi: 10.1016/j.jbiomech.2014.11.023. Epub 2014 Nov 27.

    PubMed 25553673
  • Ramadan A, Choi J, Cholewicki J, Reeves NP, Popovich JM, Radcliffe CJ. Feasibility of Incorporating Test-Retest Reliability and Model Diversity in Identification of Key Neuromuscular Pathways During Head Position Tracking. IEEE Trans Neural Syst Rehabil Eng. 2019 Feb;27(2):275-282. doi: 10.1109/TNSRE.2019.2891525. Epub 2019 Jan 10.

    PubMed 30629508
  • Ramadan A, Boss C, Choi J, Peter Reeves N, Cholewicki J, Popovich JM Jr, Radcliffe CJ. Selecting Sensitive Parameter Subsets in Dynamical Models With Application to Biomechanical System Identification. J Biomech Eng. 2018 Jul 1;140(7):0745031-8. doi: 10.1115/1.4039677.

    PubMed 29570752
  • Cholewicki J, Popovich JM Jr, Reeves NP, DeStefano LA, Rowan JJ, Francisco TJ, Prokop LL, Zatkin MA, Lee AS, Sikorskii A, Pathak PK, Choi J, Radcliffe CJ, Ramadan A. The effects of osteopathic manipulative treatment on pain and disability in patients with chronic neck pain: A single-blinded randomized controlled trial. PM R. 2022 Dec;14(12):1417-1429. doi: 10.1002/pmrj.12732. Epub 2022 Jan 18.

    PubMed 34719122

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in